Medical Breakthrough: New Treatment for Rectal Cancer Eliminates Need for Surgery
Published
Significant news arrives today for the medical world and for patients in Israel: an innovative treatment has been approved for patients with rectal cancer. The treatment is intended for adult patients in stages 2 or 3 of the disease who have not previously received treatment.
The main innovation in this treatment is the ability to fight the cancerous tumor without the need for invasive surgery or complex radiation treatments. This represents a significant shift in the therapeutic approach, which may improve patients' quality of life and reduce the severe side effects associated with traditional treatments.
The treatment is intended for patients whose tumor is characterized by a specific genetic defect, known as dMMR or MSI. Identifying the genetic defect allows doctors to tailor the medication precisely to the patient's condition, which increases the chances of the treatment's success.
Experts in the field of oncology note that this is an important step toward personalized medicine. The ability to treat a complex disease without surgical procedures is truly significant news for thousands of patients, and it may serve as a foundation for developing similar treatments for other types of cancer in the future.
Sources: היום
More Israel news
- Israel and France Explore New Approaches to Mental Health Care
- Sudden Facial Paralysis and Diabetes: What a New Israeli Study Shows
- A U.S. Medical Delegation Visited Laniado Hospital in Netanya
- A Special Crossing Over Route 6: A Bridge for Wildlife
- Revolut Receives Conditional License to Establish a Bank in Israel
- Ministry of Health Cancels Water Boiling Order in Kfar Chabad
- Eisenkot and opposition leaders agree on candidates for key Knesset positions
- Exiled Iranian Prince: Iran Is Likely to Use Nuclear Weapons Against Israel